Meclofenamate Pregnancy and Breastfeeding Warnings
Meclofenamate is also known as: Meclomen
Meclofenamate Pregnancy Warnings
Meclofenamate has not been formally assigned to a pregnancy category by the FDA; however, other nonsteroidal anti-inflammatory drugs (NSAIDs) have been assigned to FDA pregnancy category C prior to 30 weeks gestation and pregnancy category D at greater than or equal to 30 weeks gestation. Fetotoxicity, minor skeletal malformations (such as supernumerary ribs), and delayed ossification in rodent reproduction trials have been reported, but no major teratogenicity. Prolonged gestation and interference with parturition and with normal development of young before weaning have also been reported. Use of NSAIDs at greater than or equal to 30 weeks gestation may cause premature closure of the ductus arteriosus and prolong labor and delivery. There are no controlled data in human pregnancy. The manufacturer does not recommend meclofenamate for use during pregnancy.
Meclofenamate Breastfeeding Warnings
Trace amounts of meclofenamic acid are excreted in human milk. Because of the possible adverse effects of prostaglandin inhibiting drugs on neonates, a decision should be made to discontinue nursing prior to initiation of the drug.
- Meclofenamate use while Breastfeeding (in more detail)
- meclofenamate Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.